Code | 8602C | ||||||||||
MA number | 69/0231/18-S | ||||||||||
Product Form: | aer nau 1x10 g/60 dávok (fľ.HDPE s rozprašovačom) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | bottle HDPE with nebuliser | ||||||||||
Route of admin.: | Nasal use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 27.08.2018 |
SPC: | SPC_Nasometin_aer nau_08/2018_REG.doc |
PIL: | PIL_Nasometin_OTC_04/2023.pdf |
PIL: | PIL_Nasometin_Rx_04/2023.pdf |
Safety feature | No |
Data update: | 24.04.2023 |